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Abstract
Intercellular communication via gap junctions is required to coordinate developmental processes
in the mammalian embryo. We have investigated if the connexin (Cx) isoforms known to form gap
junctions in rodent preimplantation embryos are also expressed in human embryos, with the aim
of identifying species differences in communication patterns in early development. Using a
combination of polyA PCR and immunocytochemistry we have assessed the expression of Cx26,
Cx31, Cx32, Cx40, Cx43 and Cx45 which are thought to be important in early rodent embryos.
The results demonstrate that Cx31 and Cx43 are the main connexin isoforms expressed in human
preimplantation embryos and that these isoforms are co-expressed in the blastocyst. Cx45 protein
is expressed in the blastocyst but the protein may be translated from a generally low level of
transcripts: which could only be detected in the PN to 4-cell embryos. Interestingly, Cx40, which
is expressed by the extravillous trophoblast in the early human placenta, was not found to be
expressed in the blastocyst trophectoderm from which this tissue develops. All of the connexin
isoforms in human preimplantation embryos are also found in rodents pointing to a common
regulation of these connexins in development of rodent and human early embryos and perhaps
other species.
Background
An appropriate temporal and spatial pattern of intercellu-
lar junctions is needed for successful preimplantation
development and implantation in human embryos.
Experiments on rodent preimplantation embryos have
shown that the onset of E-cadherin expression is essential
for compaction [1] and expression of the tight junction
protein complex is responsible for maintaining cellular
polarity of the trophectoderm through positioning the
basolateral Na+/K+-ATPase (for review see [2]).
Both human and rodent preimplantation embryos
express an array of junctional proteins, including compo-
nents of tight junctions, desmosomes and other cell adhe-
sion molecules. While comparison of rodent and human
preimplantation embryos has shown broad similarities
between the two species there are also some notable dif-
ferences. These include the lack of detectable β3 intergrin
and later expression of ZO-2 at the transcript level in
human embryos, as well as low expression of ZO1α+ tran-
scripts and poor membrane assembly of junctional pro-
teins [3,4]. In addition to these junctional complexes,
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human preimplantation embryos, like rodent embryos
[5-7] form gap junctions [8]. Gap junctions allow the
direct exchange of ions, small metabolites, second mes-
sengers and nucleotides between the cytoplasm of neigh-
bouring cells. Each gap junction channel is formed by
docking of two hemi channels on adjacent cells and each
hemi channel is composed of six connexin subunits sur-
rounding a water filled pore. Twenty different connexin
isoforms have been identified in the human and 19 in the
mouse (for review see [9]). Variation in isoform composi-
tion of gap junctions allows diversity in the communica-
tion properties between cells of different tissues or even
between cells within the same tissue. Connexin mutations
have been identified in genetically inherited human dis-
eases (for review see [10]) suggesting that these communi-
cation channels have fundamental functions. Targeted
connexin gene deletion experiments have confirmed that
isoform composition influences the specificity of gap
junction function (for review see [9,10]) while evidence
from, targeted insertion experiments has shown that
channels are also able to share functions [11].
In human embryos Cx43 protein was shown to be
expressed throughout preimplantation development
while Cx26 and Cx32 were detected only occasionally in
the trophectoderm of late blastocyst stage embryos. Evi-
dence suggests that aberrant expression and distribution
of the Cx43 channel proteins may affect the survival
potential of human embryos [8]. In mouse and rat, tran-
scription of 8 connexin isoforms was detected during pre-
implantation development (for review see [7,12]), with
transcripts of, Cx43, Cx31, Cx31.1 and Cx45 also detected
at the protein level. Unlike the mouse, Cx26 was found at
both the mRNA and protein level in the rat blastocyst [7].
Of all the connexin isoforms, only Cx43 and Cx31 were
abundantly expressed and both were identified in the tro-
phectoderm as well as in the inner cell mass and were seen
to co localise in the same gap junctional plaque [13,14].
Despite the expression of multiple connexin isoforms, the
functional significance of heterogeneous connexin com-
position of plaques is still uncertain. Neither Cx43 nor
Cx31 gene deficiency in mice resulted in impaired preim-
plantation development or inhibited implantation. This
could indicate functional compensation for missing con-
nexin isoforms. However, experiments with Cx43 knock-
out preimplantation embryos did not show up-regulation
of other connexin isoforms while complete blocking of
communication properties had no effect on the develop-
ment or physiology of cultured mouse embryos [7]. Cx31,
Cx43 and Cx45 rapidly become segregated to different tis-
sues after implantation in mice: Cx31 is restricted to the
trophectoderm lineage and is present in the spongiotro-
phoblast of the placenta whereas Cx43 and Cx45 are the
connexins of the embryo proper [13,15]. For this reason it
is speculated that the expression of multiple connexins
allows the embryo to undergo rapid diversification into
embryonic and extraembryonic tissues. However in the
human, Cx31 has not been detected even very early in the
first trimester placenta and primary trophoblast cells.
Instead of Cx31, Cx40 is the characteristic connexin of the
proximal cells of the extravillous trophoblast which can
be functionally compared to the rodent's spongiotro-
phoblast [16,17].
In this study, we have extended our understanding of con-
nexin expression in early human embryos by examining
Cx26, Cx31, Cx32, Cx40, Cx43 and Cx45 at both tran-
script and protein level. We sought to provide further evi-
dence for the hypothesis that multiple connexin isoforms
are present in the preimplantation human embryo and
identify similarities and differences from rodent connexin
expression patterns with a view to understanding cell
communication patterns required for blastocyst
formation.
Materials and methods
All reagents were purchased from Sigma (Dorset, UK)
unless otherwise stated.
Embryos
Embryos were donated with fully informed consent by
patients being treated by in vitro fertilisation (IVF) at Leeds
General Infirmary, Leeds, UK, St Mary's Hospital, Man-
chester, UK, and Manchester Fertility Services, Whalley
Range, Manchester, UK. All research was carried out with
the permission of local ethical committees, and in accord-
ance with the licence conditions of the Human Fertilisa-
tion and Embryology Authority (HFEA: project licence
R0026). cDNAs from 3 embryos at each stage of develop-
ment were probed for connexin gene expression (as
described by Bloor et al., [3]). Antibody staining was car-
ried out on 5–6 embryos at the blastocyst stage for each
connexin protein: a total 37 embryos were used including
appropriate controls. Early cleavage stage embryos (pro-
nucleate to 8-cell-stage) were considered to be of the high-
est possible quality since they were cultured from
unselected frozen pronucleate stage embryos donated to
the programme. They were not embryos discarded from
replacement cycles. All the pronucleate, 2-cell and 4-cell-
embryos were from pregnant cycles (i.e. had siblings
which developed to term). One of the 8-cell-embryos was
from a pregnant cycle, while the two other 8-cell-embryos
were siblings from a cycle that did not result in pregnancy.
However, the donating parents were fertile since they later
achieved a spontaneous pregnancy. Embryos lysed at blas-
tocyst stage had been transferred from Leeds General Infir-
mary to the University of York at early cleavage where they
were cultured to blastocyst. These embryos had under-
gone some initial selection in that they had not been cho-
sen for replacement or freezing. However, they wereReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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clinically graded I or sometimes II and, at the time of lysis,
all were assessed morphologically to be of high quality
with >30 cells and clear evidence of an ICM. Polyspermic
or multinucleated embryos were not used in this study.
Embryo thawing
Embryos were thawed using standard clinical protocols
[18]. Briefly, they were transferred sequentially through
thawing solutions, T1 (1 M 1,2 propanediol, 0.2 M
sucrose in phosphate buffered saline (PBS)), T2 (0.5 M
1,2 propanediol, 0.2 M sucrose in PBS), T3 (0.2 M sucrose
in PBS), and T4 (IVF Universal; MediCult, UK) with 5
minutes incubation at each stage. Embryos were judged to
be viable if they survived thawing followed by 1 h in cul-
ture. The rate of survival was 85%.
Embryo culture
For culture of early cleavage stage embryos (up to 8-cell),
immediately post-thaw, embryos were transferred to 200
µl drops of pre-equilibrated medium (IVF Universal;
MediCult, UK) under oil and incubated at 37°C in 5%
CO2 in air under the standard conditions used for IVF at
St Mary's hospital. For blastocyst stages, embryos were
cultured to early cleavage stage in 70 µl drops of IVF
medium under oil (BDH) at 37°C in 5% CO2 in a humid-
ified incubator; the standard embryo culture conditions at
Leeds General Infirmary. Embryos were then transferred
to the University of York where they were cultured indi-
vidually in 4 µl drops as described previously [3,19].
Embryos were transferred to a fresh, pre-equilibrated 4 µl
drop of embryo culture medium every 24 hours.
Lysis, 3' cDNA generation and 2° amplification (polyA 
PCR)
The technique was as reported in [3] and adapted from
[20,21] and has been extensively validated [22-24]. A sin-
gle embryo was transferred in a minimum volume of cul-
ture medium (< 0.5 µl) to 4.5 µl complete lysis buffer as
in [3]. Briefly reverse transcription was carried out using
25 units (0.5 µl) of reverse transcriptase (Superscript
RNAseH-, Invitrogen, UK) at 37°C for 15 minutes, 65°C
for 10 min followed by cooling on ice. Limitation of the
reverse transcription step to 15 min resulted in the forma-
tion of cDNAs of 300–600 bp, reducing the possibility of
size-dependent preferential amplification during subse-
quent PCR amplifications and this maintains representa-
tion [24]. One volume of tailing buffer (0.33 M potassium
cacodylate, 6.7 mM CoCl2, 0.67 mM DTT, 0.16 mM dATP,
0.45 units/µl rTdT (Invitrogen, UK)) was added and the
reaction incubated at 37°C for 15 min, 65°C for 10 min.
This step polyadenylates the 1st strand cDNA, allowing
subsequent global amplification of cDNA using a single
Not1dT24 oligonucleotide primer (Invitrogen).
PCR amplification of the polyA-tailed cDNA was carried
out as previously described [3,25] by the addition of 2 vol-
umes of primary PCR reaction mix to which were added
Not1dT24 oligonucleotide primer and 0.16 units/µl Taq
polymerase). The sequence of the Not1dT24 oligonucle-
otide primer is as follows:
5'CATCTCGAGCGGCCGCTTTTTTTTTTTTTTTTTTTTTTTT
3'. Amplification was carried out using the following
cycling profile: initial denaturation at 94°C for 2 min, 25
cycles of 1 min at 94°C, 2 min at 42°C, 6 min at 72°C,
linked to a further 25 cycles of 1 min at 94°C, 1 min at
42°C, 2 min at 72°C.
The 300–600 bp primary amplification products were
subject to a further amplification as follows: 1 µl of pri-
mary PCR reaction was used as template in a 50 µl final
reaction volume containing 10 mM Tris.HCl pH 8.3, 1.5
mM MgCl2, 50 mM KCl, 0.2 mM dNTPs, 2 µM Not1dT24
oligonucleotide, 0.025 units/µl Taq polymerase. Amplifi-
cation was carried out using the following cycling profile:
initial denaturation at 94°C for 2 min followed by 50
cycles of 30 sec at 94°C, 30 sec at 54°C, 30 sec at 72°C.
Controls at each step included embryos lysed and subject
to the amplification protocol without reverse transcriptase
(RT negatives), confirming the absence of contaminating
genomic DNA and no embryo material. Human RNA
from a variety of tissues (Human total RNA master panel
II, BD Biosciences, UK) was amplified using the same pro-
tocol to produce positive control cDNA. Negative and
positive control samples were probed for the presence of
target genes in tandem with test samples as below.
Normalisation of amplified cDNA
Serial dilutions of secondary amplification products were
prepared and used as templates in a PCR reaction to
amplify β actin as in [3] using the following cycling pro-
file: initial denaturation at 94°C for 1 min followed by 23
cycles of 30 sec at 94°C, 30 sec at 62°C, 30 sec at 72°C.
10 µl of the resultant amplification products were visual-
ised following electrophoresis on a 2% agarose gel stained
with ethidium bromide. cDNA pools were discarded if no
β actin signal was detected. To probe cDNAs for the pres-
ence of test genes, the samples were diluted in the ratio
indicated from the β-actin serial dilution: normally a 10
fold concentration of the cDNA dilution at which β-actin
was just detected being used. If product could not be
detected gene-specific PCR was also attempted on undi-
luted samples but results were identical.
Gene specific PCR
Primers were designed to amplify target genes in the 500
base pairs immediately preceding the poly adenylation
signal in the gene sequence. Primers were designed using
PRIMER version 0.5 (copyright 1991, Whitehead InstituteReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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for Biomedical research). Primer pair sequences (Invitro-
gen) used in target gene amplification are shown in table
1. Where PCR products were not amplified from any
cDNA sample in the panel, a second set of primers was
designed and used to confirm the result. All amplification
products were partially sequenced to verify identity using
ABI Big dye technology (ABI, UK). For target gene ampli-
fication 1 µl of normalised cDNA was used as template in
a 25 µl final reaction volume containing 10 mM Tris.HCl
pH 8.3, 1.5 mM MgCl2, 50 mM KCl, 0.2 mM dNTPs, 1 µM
forward primer, 1 µM reverse primer, 0.025 units/µl Taq
polymerase (Roche, Lewes, UK). To remove non-specific
amplification of Cx43 product, amplification using Cx40
primers was carried out using HotMaster Taq (Eppendorf,
Cambridge, UK) according to the manufacturer's instruc-
tions. Amplification was carried out using the following
cycling profile: initial denaturation at 94°C for 1 min fol-
lowed by 50 cycles of 30 sec at 94°C, 30 sec at appropriate
annealing temperature (see Table 1), 30 sec at 72°C. Ten
µl of the resultant amplification products were visualised
following electrophoresis on a 2% agarose gel stained
with ethidium bromide. All primers successfully ampli-
fied cDNA fragments of the appropriate size from control
human cDNA
Immunocytochemistry
All embryos were double labelled to maximise the infor-
mation gained from this scarce resource with a minimum
of 5 embryos stained for each Cx isoform. Blastocysts for
immunocytochemistry were obtained from the University
of York where they were fixed in 1% paraformaldehyde in
phosphate buffered saline (PBS) prior to transportation to
the University of Manchester (in approx 14–24 h).
Embryos were recovered, washed through PBS supple-
mented with 4 mg/ml IgG free BSA (PBS/BSA, Stratech,
UK). The zona pellucida was removed by sequential incu-
bation in pronase (2.5 u/ml in PBS/BSA) for 5 mins then
acid Tyrode's for 1–2 mins. After extensive washing,
embryos were permeabilised in 0.01% Triton X-100 in
PBS/BSA for 3 mins. The embryos were washed and trans-
ferred to a 25 µl drop of primary antibody for 1 hour
under oil (Table 2). Rabbit antibodies were pre-adsorbed
with keratin prior to use to remove any anti-keratin anti-
bodies [26]. Embryos were washed then incubated in 25
µl of a second primary antibody from a different species.
After washing they were incubated in a mixture of appro-
priate secondary antibodies previously checked for cross
reactivity (Molecular Probes, UK). Nuclei were stained
using 0.25 µg/ml Hoechst 33342 in PBS/BSA for 30 min.
After final washing, embryos were transferred to a 0.1 mm
microslide (Camlab, Cambridge UK), which was sealed
then mounted onto a glass slide prior to visualisation of
staining by confocal microscopy. Microscopy was per-
formed using a BioRad MRC 600 laser scanning attach-
ment (BioRad Microscience, UK) linked to a 90 MHz
Pentium Compaq personal computer running COMOS
Version 6 control software and NiZeiss microsope or a
BioRad MRC1024 MP confocal head mounted on a Nikon
Eclipse TE300 fluorescence microscope (BioRad, UK).
Images were processed using Biorad LaserSharp software.
Controls were incubated sequentially with normal rabbit
Table 1: Gene specific amplification primers
Target Gene Primer pair sequences (5' – 3') Accession number Position in sequence Fragment Size (bp) Annealing Temp (\r C)
β actin GACAGCAGTCGGTTGGACC M10277 3163–3179 387 62
CAGGTAAGCCCTGGCTGC 3549–3532
Cx26 (a) GTTTAACGCATTGCCCAGTT M86849 874–893 174 62
TGTGGCATCTGGAGTTTCAC 1047–1028
Cx26 (b) AGGCCTGTCCAACACATCTC 1760–1779 244 64
AGGGGGTAAGCCAAACAAAC 2003–1984
Cx31 TGCAGTGGAGAGGAGGTCTT BC012918 1454–1473 184 66
CAGTTGTGGGGAGGAAGATG 1637–1618
Cx32 (a) GGGTACAAGAGATGGGATGC BC039198 1200–1219 202 64
GCCAGCAAGCACTATTCCTC 1401–1382
Cx32 (b) CCCTGGTTTTCTGGAGTCAC NM_000166 1273–1292 206 62
CCCTGCTCCAACTTATCTGC 1478–1459
Cx40 (a) TTGCAACCTTTCCTTCTGCT BC013313 1878–1897 180 64
GTGAACAGCCAAGGGAGAAA 2057–2038
Cx40 (b) CCCTGCTAGGGAGTCACTGT 1929–1948 201 62
CTGGTCAGGGTTCGAGAGAG 2129–2110
Cx43 CTGACATGCATGCAAGAAGAA BC026329 2802–2782 217 64
TCTTTTGGAGTGACCAGCAA 2586–2605
Cx45 AGATCAGGATGGCTCAGGAA U03493 1022–1041 155 64
GTTCTTCCCATCCCCTGATT 1176–1157Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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serum and mouse IgG in place of primary antibodies. All
images for test antibodies and controls were collected
using identical confocal settings and were manipulated
identically after collection.
Results
Transcript expression
All embryos in the panel expressed at least one connexin
isoform. Gene expression results are summarised in Table
3 and data are shown in Figure 1. Cx26 was detected in
one 8-cell-embryo only and Cx45 was detected in a single
pronucleate and a single 4-cell-embryo. Interestingly, no
signal for Cx40 could be amplified despite use of two
primer sets, both of which gave a positive signal with con-
trol cDNA. However, Cx31 transcripts were found in all
developmental stages in most of the embryos. Cx31 was
detected in 2/3 of the pronucleate embryos, 2/3 of the 2-
cell-embryos, 3/3 of the 4-cell-embryos, 2/3 of the 8-cell-
embryos and 2/3 of the blastocysts. Cx43 was detected in
all pronucleate embryos, 2/3 of the 2-cell-embryos 1/3 of
the 4-cell-embryos and all 8-cell and blastocyst stage
embryos. No transcripts of Cx32 were found at any stage
of preimplantation development.
Immunocytochemistry
Immunocytochemistry was used to investigate protein
expression for Cxs26, 31, 40, 45 and 43 in fixed human
blastocysts (Table 4) For Cx26, 5/6 embryos were positive
for the protein, and in the same embryo cohort, 5/6 of
these embryos also showed staining for Cx43. The same
embryo was negative for both Cx26 and Cx43. Some cor-
relation was seen between intensity of staining for Cx26
and 43. For Cx31, only 1/5 of the embryos were stained
and in the same cohort 3/5 showed staining for Cx43.
Again, there was some correlation between Cx31 and 43
staining, with 2/5 embryos negative for both proteins and
the single Cx31 positive embryo showing the only bright
junctional staining observed with Cx43. When Cx45 was
examined, 4/6 embryos showed staining while 5/6
showed staining for Cx43. One of the embryos was nega-
tive for both Cx45 and Cx43. The bright punctuate stain-
ing of both Cx31 and Cx45 showed complete
colocalisation with Cx43, and there was also approxi-
mately 50% colocalisation between Cx26 and Cx43
protein staining. No staining could be detected above
background in 6 embryos stained for Cx40. Representa-
tive images of positively stained embryos are shown in
Figure 2.
Table 2: Antibodies used in immunocytochemistry
Antigen Antibody Isotype Dilution Secondary Antibody Dilution
Cx26 Rabbit polyclonal [34] 1:1000 Alexa fluor 546, goat anti rabbit IgG 1:125
Cx31 Rabbit polyclonal [35] 1:300 Alexa fluor 546, goat anti rabbit IgG 1:125
Cx40 Rabbit polyclonal [36] 1:100 Alexa fluor 546, goat anti rabbit IgG 1:125
Cx43 Mouse IgG (Zymed) 1:500 Alexa fluor 488, goat anti mouse IgG 1:125
Cx45 Rabbit polyclonal [35] 1:500 Alexa fluor 546, goat anti rabbit IgG 1: 125
Table 3: Transcript expression
PN 2 cell 4 cell 8 cell Blastocyst
G e n e 123123123123123
β a c t i n +++++++++++++++
C x 2 6 ---------+-----
C x 3 1 ++- -+++++++-+-+
C x 3 2 ---------------
C x 4 0 ---------------
C x 4 3 ++++-+-+-++++++
C x 4 5 -+-+---+-------
Expression of β actin, connexins 26, 31, 32, 40, 43 and 45 in cDNAs amplified from three individual embryos (1,2,3) at the pronucleate (PN), 2-cell, 
4-cell, 8-cell, and blastocyst stages of development. + denotes trancript detected, – denotes transcript not detected.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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Discussion
The present study revealed several connexin isoforms in
developing preimplantation human embryos identified at
the transcript and/or protein level, Cx26, Cx31, Cx43 and
Cx45, whereas Cx32 and Cx40 were not detectable. This
study extends the observations of Hardy et al. [8] that
diverse connexin proteins are expressed in human preim-
plantation embryos in a similar pattern to that seen in
rodents. In addition, the present study confirms that Cx43
is the predominant transcript as well as the predomi-
nantly expressed gap junction protein in human preim-
plantation embryos. Because of limited availability of
human embryos we focused on those connexins identi-
fied as playing an important role in early embryonic and
placental lineage development in rodents such as Cx43
and Cx45 for the embryo proper [13,15] and Cx31 for pla-
cental development [13,14]. Cx45 transcripts were
detected in one third of PN and early cleavage stage
embryos but not in later embryos, although the protein
was expressed by blastocysts. This suggests that transcripts
are generally at extremely low abundance and not
detected in this study. However, it might also indicate that
there is a delay between transcript synthesis and transla-
tion and protein assembly as has been found for junc-
tional components in the mouse [27]. In contrast to the
observation of Hardy and colleagues on Cx proteins [8],
Cx32 transcript was not seen in our investigations. How-
ever, we did identify a weak band for Cx26 transcripts at
the 8-cell-stage and immunoreactivity in the blastocyst
stage. This may suggest that Cx26 transcripts are present at
very low levels. It is notable that Cx32 and Cx26 proteins
were only observed occasionally in late blastocysts by
Hardy et al. [8]. This may suggest that these connexins
appear prior to implantation and that the lack of Cx32
staining relates to differences in blastocyst developmental
maturity. However these differences may be due to the
response of human embryos to the different culture con-
ditions used in the two studies [8]. Cx26 has been found
in rat but not in mouse preimplantation embryos. The
question arises as to the function of those weakly or
inconsistently expressed genes.
In rodents, Cx31 represents a marker gene for the extrae-
mbryonic cell lineages but this has not been observed in
PCR amplification of Cx26, Cx31, Cx32, Cx40, Cx43 and Cx45 from cDNAs amplified from three individual embryos (1,2,3) at  the pronucleate (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), and blastocyst stages of development Figure 1
PCR amplification of Cx26, Cx31, Cx32, Cx40, Cx43 and Cx45 from cDNAs amplified from three individual embryos (1,2,3) at 
the pronucleate (PN), 2-cell (2C), 4-cell (4C), 8-cell (8C), and blastocyst stages of development. N denotes negative control; P 
denotes positive control.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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humans. In this study, we therefore tried to elucidate the
role of Cx40, which plays a major role in development of
the human placenta [16,28,29]. Cx40 is found in the early
human placenta in the extravillous trophoblast cell popu-
lation which is functionally analogous to the spongiotro-
phoblast [16,30]. It appears to be produced instead of
Cx31 which is expressed during mouse placental develop-
ment in the spongiotrophoblast but is absent during
human placental development. However, transcripts for
Cx40 were not detected at any stage of human early devel-
opment, nor was the protein observed at the blastocyst
stage. This is in contrast to the trophoblast associated tran-
scription factor Hand-1 which is expressed from the 4-cell
stage and in blastocyst trophectoderm in human embryos
[31]. Hand-1 is essential for differentiation of murine tro-
phoblast giant cells after implantation and these cells
have similar behaviour to human extravillous cytotro-
phoblast [32]. Interestingly, Cx31 expression was
observed in human blastocysts. Transcripts were detected
in all the 4-cell-stage embryos and 4/6 of the 8-cell
embryos and blastocysts. However, except for one
embryo, the corresponding protein was only detectable as
a weak cytoplasmic fluorescence in the blastocyst suggest-
ing that the protein only rarely forms functional gap junc-
tions in the human embryo. It may be translated to only a
limited extent in preimplantation human embryos or
assembly may occur late in the blastocyst stage after
hatching. This expression pattern differs from that seen in
Confocal images of fixed human blastocysts showing protein  localisation of Cx26, Cx31, and Cx45 (shown in red) and  colocalisation (shown in yellow) with Cx43 (shown in green)  (Cx26/43, Cx31/43, Cx45/43) Figure 2
Confocal images of fixed human blastocysts showing protein 
localisation of Cx26, Cx31, and Cx45 (shown in red) and 
colocalisation (shown in yellow) with Cx43 (shown in green) 
(Cx26/43, Cx31/43, Cx45/43). Nuclei are shown in blue. 
Negative control images of blastocysts incubated with mouse 
IgG (mIgG) and rabbit pre-immune serum (RPI). Scale bars = 
25 µm.
Table 4: Summary of staining human blastocysts with anti-
connexin antibodies
Embryo Cx43 Cx26 Cx31 Cx45 Cx40
1+ +
2+ +
3+ +
4+ +
5- -
6+ +
7+ -
8+ +
9- -
10 - -
11 + -
12 + +
13 + +
14 + +
15 + +
16 - -
17 + -
18 + -
19 + -
20 + -
21 - -
22 - -
23 + -
Individual human blastocysts were stained with antibodies to Cx 
43,26, 31, 45 and 40 as indicated in materials and methods. Double 
staining with Cx43 and one other connexin was carried out in each 
case. +, specific staining detected; -, no staining detected.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/25
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rodent preimplantation embryos which express Cx31 and
Cx43 in the same spatiotemporal pattern during preim-
plantation development. It is possible that the failure to
detect significant Cx31 protein could reflect a loss of
embryo viability as a result of extended culture [8].
Hardy et al. [8] showed that early human embryos express
predominantly Cx43 proteins and that protein levels
increase during preimplantation development up to the
blastocyst stage. This observation is supported by our
studies. Cx43 transcripts were detected in nearly all
embryos and the protein was present in 74% of the blast-
ocyst stage embryos observed. The Cx43 protein was, in
most cases, arranged along the cell borders in the expected
typical punctuate pattern. We have previously found that
the uniform assembly of junctional components observed
for mouse embryos, is often not seen in human embryos
which show a more patchy distribution [3]. Double
immunolabelling of this dominant protein with other
connexin isoforms did not provide evidence for sorting of
the connexins between the trophectoderm and inner cell
mass compartments. Though staining for Cx26, Cx31 and
Cx45 was lower than for Cx43, they exhibited mostly
coexpression with Cx43, probably in the same gap junc-
tion plaque. These findings are again in accordance with
observations in rodent blastocysts where Cx31 and Cx43
colocalize in the same gap junction plaque [13,14]
although other data suggests these may not cooperate to
form functional channels [33]. Indeed, staining patterns
for all the connexin proteins investigated indicated lack of
any obvious compartmentalisation between the two blas-
tocyst cell populations. Though all embryos investigated
were of good morphology, they exhibited variability in
connexin pattern at the protein level. It was obvious from
double staining that when Cx43 was missing or poorly
expressed in an embryo then the other connexin isoform
assessed was missing too. It remains to be seen if this is
related to the viability of the embryos or to the effects of
processing. Identification of the presence and location of
intercellular junctional proteins including gap junction
components could help characterize the quality of
embryos in culture. For example, Ghassemifar et al. [4]
investigated the tight junction complex in human
embryos, including JAM and desmocollin and showed
that the level of junctional transcript was positively
correlated to the morphological grade. Gap junction com-
ponents such as Cx31 and Cx43 seem to be additional
marker molecules for orderly embryonic development in
culture.
Conclusion
Cx43, Cx31 and Cx45 appear to be the main connexin iso-
forms expressed in human preimplantation embryos and
these proteins are coexpressed in the blastocyst: a pattern
which resembles that of rodent preimplantation embryos.
Low or undetectable transcript levels for Cx26 together
with weak protein expression in the blastocyst suggest that
this protein is less critical to gap junction function while
Cx45 protein may be assembled in the blastocyst from
protein translated from a generally low level of transcripts.
Cx40, the connexin characteristic of extravillous trophob-
last in early human placentas, is not present in blastocyst
trophectoderm. The similarities in connexin expression in
the human blastocyst compared to the rodents suggest
that in preimplantation development different species are
using common mechanisms of intercellular communica-
tion for blastocyst formation.
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